Pablo Conesa-Zamora
Overview
Explore the profile of Pablo Conesa-Zamora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
627
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alburquerque-Gonzalez B, Montoro-Garcia S, Bernabe-Garcia A, Bernabe-Garcia M, Campioni-Rodrigues P, Rodriguez-Martinez A, et al.
Biomed Pharmacother
. 2024 Sep;
179:117411.
PMID: 39256102
No abstract available.
2.
Kinoshita H, Martinez-Ordonez A, Cid-Diaz T, Han Q, Duran A, Muta Y, et al.
Dev Cell
. 2024 May;
59(15):1972-1987.e8.
PMID: 38815584
The early mechanisms of spontaneous tumor initiation that precede malignancy are largely unknown. We show that reduced aPKC levels correlate with stem cell loss and the induction of revival and...
3.
Alburquerque-Gonzalez B, Montoro-Garcia S, Bernabe-Garcia A, Bernabe-Garcia M, Campioni-Rodrigues P, Rodriguez-Martinez A, et al.
Biomed Pharmacother
. 2024 May;
175:116785.
PMID: 38781869
Rearrangement of the actin cytoskeleton is a prerequisite for carcinoma cells to develop cellular protrusions, which are required for migration, invasion, and metastasis. Fascin is a key protein involved in...
4.
Muta Y, Linares J, Martinez-Ordonez A, Duran A, Cid-Diaz T, Kinoshita H, et al.
Nat Commun
. 2023 Dec;
14(1):8075.
PMID: 38092754
The metabolic and signaling pathways regulating aggressive mesenchymal colorectal cancer (CRC) initiation and progression through the serrated route are largely unknown. Although relatively well characterized as BRAF mutant cancers, their...
5.
Asensi-Canto A, Rodriguez-Braun E, Beltran-Videla A, Hurtado A, Conesa-Zamora P
Front Oncol
. 2023 Oct;
13:1238464.
PMID: 37841433
Background: Tumor invasion and metastasis are responsible for the majority of cancer-related deaths. The identification of molecules involved in these processes is crucial to design effective treatments that can halt...
6.
Santamarina-Garcia M, Brea-Iglesias J, Bramsen J, Fuentes-Losada M, Caneiro-Gomez F, Vazquez-Bueno J, et al.
iScience
. 2023 Mar;
26(3):106127.
PMID: 36879816
Deficiency in DNA MMR activity results in tumors with a hypermutator phenotype, termed microsatellite instability (MSI). Beyond its utility in Lynch syndrome screening algorithms, today MSI has gained importance as...
7.
Alburquerque-Gonzalez B, Lopez-Abellan M, Luengo-Gil G, Montoro-Garcia S, Conesa-Zamora P
Methods Mol Biol
. 2022 Sep;
2547:165-185.
PMID: 36068464
The good clinical results of immune checkpoint inhibitors (ICIs) in recent cancer therapy and the success of RNA vaccines against SARS-nCoV2 have provided important lessons to the scientific community. On...
8.
Asensi-Canto A, Lopez-Abellan M, Castillo-Guardiola V, Hurtado A, Martinez-Penella M, Luengo-Gil G, et al.
Cancers (Basel)
. 2022 Jul;
14(13).
PMID: 35805019
Growing evidence shows that nerves play an active role in cancer development and progression by altering crucial molecular pathways and cell functions. Conversely, the use of neurotropic drugs, such as...
9.
Luengo-Gil G, Conesa-Zamora P
Glob Chall
. 2022 Mar;
6(3):2100051.
PMID: 35284089
Today, an unprecedented understanding of the cancer genome, along with major breakthroughs in oncoimmunotherapy, and a resurgence of nucleic acid vaccines against cancer are being achieved. However, in most cases,...
10.
de Alarcon R, Alburquerque-Gonzalez B, Fernandez-Valera A, Molina-Nunez M, Alvarez Fernandez G, Consuegra-Sanchez L, et al.
Nephrol Dial Transplant
. 2021 Dec;
37(4):792-795.
PMID: 34888693
No abstract available.